The FDA has only approved three GLP-1 drugs specifically for weight loss - the semaglutide Wegovy, the liraglutide Saxenda, and the tirzepatide Zepbound- and the rest are specifically for patients suffering from type 2 diabetes (picturedMay 8)

The FDA has only approved three GLP-1 drugs specifically for weight loss - the semaglutide Wegovy, the liraglutide Saxenda, and the tirzepatide Zepbound- and the rest are specifically for patients suffering from type 2 diabetes (picturedMay 8)

Image Hash: 71f1eb63333332f2
Date: October 17, 2025